This conference brings together researchers from academic institutions and industry to discuss the utilization/deployment of biomarkers in research settings, the clinic, and point-of-care (POC) setting.
The focus of the conference begins with oncology (cancer) biomarkers but continues beyond into other disease areas such as cardiovascular disease biomarkers, CNS biomarkers, diabetes biomarkers, renal biomarkers, hepatic disease biomarkers.
Various classes of biomarkers are presented in this conference: Classical cancer biomarkers, molecular signatures for cancer based on gene expression profiles, microRNA-based biomarkers, protein expression-based biomarkers, and epigenetic biomarkers.